diff --git a/docs/marketing/seo/2026-04-16-brand-discoverability.md b/docs/marketing/seo/2026-04-16-brand-discoverability.md new file mode 100644 index 00000000..b4421c51 --- /dev/null +++ b/docs/marketing/seo/2026-04-16-brand-discoverability.md @@ -0,0 +1,215 @@ +# Brand Discoverability Brief: "Molecule AI" SERP Pollution +**Date:** 2026-04-16 +**Owner:** SEO / Growth Analyst +**Trigger:** Social Media Brand audit flag, 20:00 2026-04-16 +**Status:** Active — feeds PMM brand naming conversation + +--- + +## Executive Summary + +The brand name "Molecule AI" is severely polluted. A full audit of the head-term SERP today shows **zero results for our product in the top 10 results** — every slot is occupied by drug-discovery and biotech companies. Our product does not appear in any developer-intent search without additional qualifiers, and even those modifier queries are unowned. This is not a fixable-with-content problem alone; it warrants a formal PMM conversation about whether the brand needs a persistent qualifier in developer contexts. + +**Pollution severity: 9/10 (critical)** + +--- + +## 1. Pollution Audit: Top 10 SERP for "Molecule AI" (2026-04-16) + +| Rank | Result | Owner | Relevant to us? | +|------|--------|-------|----------------| +| 1 | moleculeai.com | Molecule AI Pvt. Ltd. (Delhi) — drug discovery SaaS, MoleculeGEN platform | ❌ Noise | +| 2 | linkedin.com/company/molecule-ai | LinkedIn page — description reads "AI-based drug design" | ❌ Noise (their page) | +| 3 | moleculeai.io | AI Powered Molecular Intelligence — drug/target interaction | ❌ Noise | +| 4 | playmolecule.ai | PlayMolecule — computational chemistry platform | ❌ Noise | +| 5 | molecule.one | Making Molecules / Discovering Chemistry | ❌ Noise | +| 6 | shuttlepharma.com article | Shuttle Pharma LOI to acquire molecule.ai | ❌ Noise | +| 7 | icahn.mssm.edu | Icahn School of Medicine AI Drug Discovery Center | ❌ Noise | +| 8 | moleculeai.com/products | Molecule AI drug discovery products page | ❌ Noise | +| 9 | shuttlepharma.com article #2 | Second molecule.ai acquisition announcement | ❌ Noise | +| 10 | eisai.com | Eisai pharmaceutical AI-driven drug design | ❌ Noise | + +**Score: 0/10 results are ours.** + +Additional collision surfaces discovered: +- **moleculeai.tech** — a blockchain/crypto project also calling itself "MoleculeAI" (Base-powered SDK, MOLAI token) — a third-namespace collision in developer spaces +- **github.com/MolecularAI** — owned by AstraZeneca (REINVENT4 molecular design tool, 1k+ stars) — appears in developer searches and is easily confused +- **Multiple LinkedIn entities** named "Molecule AI" — drug-discovery companies have established pages + +--- + +## 2. Handle & SERP Ownership Assessment + +### Google SERP — Modifier Queries + +| Query | Do we appear? | Who does appear? | +|-------|--------------|-----------------| +| "Molecule AI developer platform" | ❌ No | Generic AI orchestration roundups (IBM, Kore.ai, Domo) | +| "Molecule AI agents" | ❌ No | Generic multi-agent framework articles | +| "Molecule AI orchestration" | ❌ No | Generic orchestration guides (LangChain, CrewAI) | +| "molecule.ai agents" | ❌ No | moleculeai.com drug-discovery products page | +| "Molecule AI runtime" | ❌ No | Generic agent runtime articles | + +**We own zero SERP slots — not even the branded modifier queries.** There is no Google Knowledge Panel for us; when one appears, it will likely be for the drug-discovery companies given their domain authority and Crunchbase/LinkedIn establishment. + +### X (Twitter) Handle + +| Handle | Status | Notes | +|--------|--------|-------| +| @molecule_ai | Ours (confirmed) | **17 posts total** — extremely low activity; profile is not discoverable in X search for "molecule ai developer" | +| X bio/description | Unknown | Not visible in SERP snippet; needs to explicitly say "AI agent platform" to disambiguate | + +**Assessment:** @molecule_ai is the right handle but the account is nearly dormant (17 posts). X's algorithm surfaces accounts by follower count × recency × keyword match. At 17 posts we will not surface for any brand-related X search. Drug-discovery companies with active social presences will dominate X search for "Molecule AI" just as they dominate Google. + +### LinkedIn + +The LinkedIn `company/molecule-ai` page appears in SERP but the description snippet that Google indexes reads as drug-design content — meaning the page may belong to the drug-discovery "Molecule AI" company, not us, or our page description is absent/wrong. Either way, our developer identity is not present on LinkedIn's version of our brand name. + +--- + +## 3. Top 3 Actionable Recommendations + +Ranked by impact × speed. Full option matrix follows. + +--- + +### Recommendation 1 (Highest impact): Publisher Strategy — Own the Developer Modifier SERP Immediately + +**The insight:** The head term "Molecule AI" is unwinnable in the short term — drug-discovery companies have domain authority, press coverage, Crunchbase profiles, and 3+ years of indexed content. But **every developer-modifier combination is completely empty.** No competitor (drug-discovery or otherwise) has published content targeting: +- "Molecule AI agent platform" +- "Molecule AI orchestration" +- "Molecule AI runtime" +- "Molecule AI developer" +- "Molecule AI multi-agent" + +These are our brand name + our product category. We can own 100% of this modifier SERP within 60–90 days with consistent publishing. + +**Specific actions:** + +1. Every blog post, doc page, press mention, and social post should include the phrase "Molecule AI agent platform" or "Molecule AI multi-agent runtime" — written out, not shortened. This is a content instruction, not a style preference. +2. The homepage `` tag should read: `Molecule AI — AI Agent Platform for Developers` (not just `Molecule AI`). +3. Homepage and `/about` H1 must include: "The AI agent platform built for developers" with "Molecule AI" in the page's `<h1>` or prominent above-the-fold text — Google uses this to anchor the entity. +4. Publish 3 anchor pieces targeting modifier queries (see Keyword Targets below). + +**Effort:** Low-Medium (content + on-page changes). **Timeline:** 30–60 days to first ranking. + +--- + +### Recommendation 2 (Medium impact, fast): Organization Schema + Knowledge Panel Claim + +**The insight:** Google serves a Knowledge Panel for "Molecule AI" if it can find a confident entity match. Right now it's returning drug-discovery content because those companies have structured data (Crunchbase, Wikipedia/Wikidata, LinkedIn pages with descriptions) and we don't. + +**Specific actions:** + +1. **Add `Organization` JSON-LD to `<head>` of homepage immediately:** +```json +{ + "@context": "https://schema.org", + "@type": "Organization", + "name": "Molecule AI", + "description": "AI agent platform for developers. Build, deploy, and orchestrate multi-agent systems across any runtime.", + "url": "https://molecule.ai", + "logo": "https://molecule.ai/logo.png", + "foundingDate": "2024", + "applicationCategory": "DeveloperApplication", + "sameAs": [ + "https://x.com/molecule_ai", + "https://github.com/Molecule-AI", + "https://www.linkedin.com/company/molecule-ai" + ] +} +``` + +2. **Create a Wikidata entity** for Molecule AI (our company). Wikidata is Google's primary Knowledge Graph source. Requirements: 3+ independent citations (press articles, blog mentions). We need to produce/earn these via DevRel outreach and release announcements. +3. **Claim/verify Google Search Console** for all owned properties and submit updated sitemap. +4. **Ensure NAP consistency** (Name/Address/Email) across Crunchbase, LinkedIn, AngelList, GitHub org description, and website footer — Google uses inconsistency as a signal to de-prioritize a Knowledge Panel. + +**Effort:** Low (schema = 1 hour dev work). **Timeline:** Schema helps within 2–4 weeks; Knowledge Panel takes 60–90 days after citations are established. + +--- + +### Recommendation 3 (Strategic): X Bio + Cadence Fix to Reclaim Social Discoverability + +**The insight:** @molecule_ai with 17 posts is invisible. X's search surfaces accounts by bio keyword match + account authority. Our bio must explicitly contain "AI agent platform" and we need a minimum content floor to rank in X search. + +**Specific actions:** + +1. **Update X bio immediately** to: `AI agent platform for developers. Build and deploy multi-agent systems across Gemini CLI, Claude Code, and any runtime. #AIAgents #DevTools` +2. **Pinned post:** Publish a pinned tweet explicitly about Molecule AI as a developer agent platform — this is what X surfaces first when someone clicks our profile from search. +3. **Cadence floor:** Minimum 5 posts/week to build account authority. Below this threshold, X algorithm will not surface us for brand queries. Coordinate with Social Media Brand to set this. +4. **Handle assessment:** @molecule_ai is fine and defensible — do NOT change it. Changing handles destroys existing follower graph and creates dead-link problems. If APAC developer audiences are underserved, consider a secondary handle (@moleculeai_dev or @moleculeai_apac) but only after primary handle activity is healthy. + +**Effort:** Very low (bio update = 5 minutes; cadence = editorial calendar item). **Timeline:** X discoverability improves within 2–4 weeks of consistent posting. + +--- + +## 4. Quick Wins vs. 30-Day Plays + +### Quick Wins (This Week, ≤3 Days Each) + +| Action | Owner | Time | +|--------|-------|------| +| Update `<title>` tag on homepage to `Molecule AI — AI Agent Platform for Developers` | Frontend Engineer | 1 hr | +| Add `Organization` JSON-LD schema to homepage `<head>` | Frontend Engineer | 1 hr | +| Update X bio to include "AI agent platform" and "multi-agent" keywords | Social / Marketing | 15 min | +| Publish pinned tweet explicitly positioning Molecule AI as a developer agent platform | Social / Marketing | 30 min | +| Audit and correct LinkedIn company page description (ensure ours says "AI agent platform", not drug design) | Marketing Lead | 30 min | +| Add Molecule AI to Crunchbase with correct category ("Developer Tools", "AI/ML") | Marketing Lead | 1 hr | +| Ensure GitHub org description reads "AI agent platform — multi-agent orchestration for developers" | Dev Lead | 15 min | + +**Combined quick-win impact:** These 7 actions take <1 day total and immediately begin building the entity disambiguation signal Google needs to separate us from drug-discovery noise. + +### 30-Day Plays + +| Action | Owner | Timeline | +|--------|-------|----------| +| Publish 3 anchor blog posts targeting "Molecule AI agent platform", "Molecule AI orchestration", "Molecule AI runtime" | Content + SEO | Week 2–4 | +| Earn 3+ independent press citations (launch announcement, ProductHunt, Hacker News Show HN) | Marketing Lead + DevRel | Week 2–4 | +| Create Wikidata entity with citations | SEO | Week 3–4 (requires citations first) | +| Bring X posting to minimum 5/week cadence | Social | Ongoing from Week 1 | +| Build `/about` page with full company description, team, schema markup | Frontend + Content | Week 2–3 | +| File for Google Knowledge Panel verification (via Search Console + Wikidata) | SEO | Week 4 (after citations exist) | +| Add Molecule AI to developer tool directories: There's An AI For That, Futurepedia, AI Tools Directory | Marketing | Week 2 | +| Request coverage in "AI agent frameworks" roundup articles (currently appearing in: KDNuggets, Vellum.ai, Guideflow) | DevRel | Week 3–4 | + +--- + +## Branded Search Term Ownership Plan + +These are the modifier queries we should own within 90 days. Each needs at least one page/post anchoring it: + +| Target Term | Content Vehicle | Current Rank | +|------------|----------------|-------------| +| `Molecule AI agent platform` | Homepage, /about | ❌ Unranked | +| `Molecule AI orchestration` | Blog post (anchor) | ❌ Unranked | +| `Molecule AI runtime` | /runtimes index + blog | ❌ Unranked | +| `Molecule AI multi-agent` | Blog post | ❌ Unranked | +| `Molecule AI developer` | Blog + docs | ❌ Unranked | +| `Molecule AI Gemini` | /runtimes/gemini-cli (in progress — #514) | ❌ Unranked | +| `molecule.ai agents` | Homepage (canonical domain claim) | ❌ Unranked | + +--- + +## 5. Flag: Does This Warrant a Brand Naming Conversation with PMM? + +**Yes. Recommend escalating.** + +The collision is not cosmetic. The drug-discovery "Molecule AI" namespace is: +- Established with funded companies (Shuttle Pharma acquisition underway) +- Active in PR/press (Shuttle Pharma press releases dominate Google News) +- Occupying the exact domain variants we cannot acquire (moleculeai.com, moleculeai.io) +- Producing content that will only grow as APAC pharma AI investment increases + +**Risk horizon:** If Shuttle Pharma completes the moleculeai.io/molecule.ai acquisition, their combined entity becomes a well-funded, PR-active brand with our exact name in the pharmaceutical AI space. Google, X, and LinkedIn will further consolidate results toward them. + +**PMM conversation agenda:** +1. Should "Molecule AI" carry a persistent developer qualifier in all marketing contexts? Options: `Molecule AI Platform`, `Molecule AI (DevTools)`, `Molecule — AI Agent Platform` +2. Is there a differentiated handle strategy worth pursuing? Options: @moleculeai_dev, @molecule_agents, @getmoleculeai +3. What is the threshold for a brand rename vs. a qualifier strategy? (Estimate: if drug-discovery companies consolidate under the name within 12 months, a rename is cheaper than SEO remediation) +4. Can we acquire molecule.ai domain or molecule.dev as a canonical domain redirect? + +**My recommendation:** Don't rename now, but adopt "Molecule AI Platform" as the consistent long-form in all B2B/developer contexts and double down on the developer-modifier SERP ownership strategy above. Revisit in 90 days after measuring whether modifier queries are ranking. + +--- + +*Generated by SEO / Growth Analyst — 2026-04-16. Data: web SERP audit, X handle research, LinkedIn brand audit, competitive landscape analysis.*